Skip to content

Effect of solution focused of spouse abuse

The effect of solution focused approach on the coping and resilience of women victims of spouse abuse

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240704062329N1
Enrollment
60
Registered
2024-07-23
Start date
2024-07-22
Completion date
Unknown
Last updated
2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Women victims of spouse abuse.

Interventions

Intervention 1: Intervention group: The intervention of this research is short-term solution oriented counseling. After the pre-test, the members of the intervention group will benefit from short-term

Sponsors

Arak University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 39 Years

Inclusion criteria

Inclusion criteria: Age 18 to 39 years Having at least one year of cohabitation with a spouse Having experienced violence from the husband at least during the last year (getting at least one score from the subscales of physical assault, psychological aggression, negotiation, sexual coercion and injury of the aggressive form of the CTS2 questionnaire) Obtaining a resilience score of <50 from the Connor and Davidson questionnaire Ability to understand and speak Persian Having at least a third middle school degree Having Iranian nationality Having a permanent marriage and being married at the moment Absence during pregnancy and postpartum period (up to 6 months after delivery) Failure to simultaneously participate in counseling courses with the same content as the present intervention Not experiencing any severe stressors such as divorce, accident and bereavement of relatives in the last 6 months

Exclusion criteria

Exclusion criteria: Taking psychotropic drugs including anti-anxiety drugs (such as clonazepam, alprozolam, lorazepam), antidepressants (such as fluoxetine, paroxetine, sertraline), antipsychotic drugs (such as chlorpromazine, fluphenazine, haloperidol), mood stabilizers (such as lithium, carbamazepine, sodium valproate) ) and stimulants (such as amphetamine, dexmethylphenidate, dextroamphetamine) within 6 months before participating in the study and during the study Having a history of hospitalization in the neurology department Having any underlying and incurable diseases such as cancer or malignant tumors Abuse of alcohol and drugs in yourself or your spouse Having impaired consciousness

Design outcomes

Primary

MeasureTime frame
Coping score in the coping inventory for intimate partner violence. Timepoint: Measurement time, before the start of the intervention (pre-test), immediately after the end of the intervention (post-test), 4 weeks and 12 weeks after the last session of the intervention (follow-up). Method of measurement: Coping is measured with Coping Inventory for Intimate Partner Violence (CIIPV)uestionnaire designed by Taherkhani (2022).

Secondary

MeasureTime frame
Resilience score in the questionnaire Connor-Davidson Resilience Scale. Timepoint: The measurement time is before the start of the intervention (pre-test), immediately after the end of the intervention (post-test), 4 weeks and 12 weeks after the last session of the intervention (follow-up). Method of measurement: Resilience is measured by Conner and Davidson's (2003)Connor-Davidson Resilience Scale (CD-RISC).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHadiseh Arab

Arak University of Medical Sciences

arabhadise95940321189@gmail.com+98 86 3277 3426

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026